Home

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (GSK)

39.85
+0.33 (0.84%)
NYSE · Last Trade: Sep 28th, 8:00 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
Amgen Expands US Manufacturing Network Amid New Tariff Policybenzinga.com
Just when the Trump administration announced a 100% tariff on pharmaceuticals starting in October, Amgen Inc (NASDAQ: AMGN) announced a $650 million expansion of its U.S. manufacturing network.
Via Benzinga · September 26, 2025
Trump's 100% Pharmaceutical Tariff: The $270 Billion Manufacturing War That Could Reshape Your Medicine Cabinetbenzinga.com
Trump’s sweeping 100% pharmaceutical tariff starting October 1 triggers massive $270 billion industry investment surge, creating clear stock market winners like Eli Lilly while foreign-de
Via Benzinga · September 26, 2025
Robert F. Kennedy Jr. Faces Impeachment Push From Haley Stevens Over 'Health Care Chaos' And Rising Costs: 'Enough Is Enough'benzinga.com
Rep. Haley Stevens (D-Mich.) announced that she will introduce articles of impeachment against Health and Human Services Secretary Robert F. Kennedy Jr.
Via Benzinga · September 26, 2025
Kenvue Stock Hits Record Low As Trump Urges Pregnant Women To ‘Fight Like Hell’ Against Tylenol: Retail Stays Bullishstocktwits.com
Via Stocktwits · September 22, 2025
Wave Life Sciences Tumbled 19% Today, But Not Everyone’s Disappointed – Find Out Whystocktwits.com
Via Stocktwits · September 3, 2025
What's Driving the Market Sentiment Around GSK?benzinga.com
Via Benzinga · September 3, 2025
Kenvue Bounces Off Record Low: A Deep Dive into its Rebound and Future Prospects
Kenvue (NYSE: KVUE), the consumer health giant spun off from Johnson & Johnson, has experienced a significant rebound in its stock price, climbing notably from a recent record low. This resurgence comes after a period of intense pressure, primarily fueled by controversial, unproven claims linking its flagship Tylenol product to neurodevelopmental
Via MarketMinute · September 24, 2025
Trump Advises Parents To Split Vaccines, Delay Hepatitis B Shots Until Age 12: 'This Is Based On What I Feel'benzinga.com
President Donald Trump on Monday offered advice on childhood vaccination schedules, encouraging parents to split up certain immunizations and delay certain others, in sharp contradiction to current medical recommendations.
Via Benzinga · September 22, 2025
Elizabeth Warren Says Measles Can Hit Record Highs, Slams RFK Jr.'s CDC Panel For Delaying Vaccine: 'How Does That Keep Our Kids Safe?'benzinga.com
Sen. Elizabeth Warren (D-Mass.) on Thursday criticized the Centers for Disease Control and Prevention's vaccine advisory panel following its controversial vote to delay the combined measles, mumps, rubella, and varicella or MMRV vaccine for children under 4 years old.
Via Benzinga · September 18, 2025
GSK Secures UK Approval For First New Oral Antibiotic In 30 Years To Treat Resistant Urinary Tract Infectionsstocktwits.com
Via Stocktwits · August 27, 2025
Price Over Earnings Overview: GSKbenzinga.com
Via Benzinga · August 27, 2025
GSK To Pour $30 Billion Into US R&D, Manufacturing Over Five Yearsbenzinga.com
GSK will invest $30 billion in U.S. R&D and manufacturing, including a new biologics factory, AI upgrades, and expanded drug and device capabilities.
Via Benzinga · September 17, 2025
Dow Futures Stall Ahead Of Fed’s Interest Rate Decision Today: WDAY, MSFT, GOOGL, NVDA Among Stocks To Watchstocktwits.com
While Dow Jones futures were up 0.03% at the time of writing, the S&P 500 futures fell 0.07%.
Via Stocktwits · September 17, 2025
GSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In Americastocktwits.com
The plan includes $1.2 billion for a new biologics factory in Upper Merion, Pennsylvania, along with AI upgrades and expanded drug production across existing U.S. sites.
Via Stocktwits · September 16, 2025
Robert Kennedy Jr. Packs CDC Panel With Vaccine Skeptics Ahead of Key Vote On COVID-19 Shotsbenzinga.com
Health and Human Services Secretary Robert F. Kennedy Jr. has added five new members to the Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices, just days before it reconvenes to vote on COVID-19 shots and other routine pediatric vaccine recommendations.
Via Benzinga · September 15, 2025
Recent Report Shows That Rep. Robert Aderholt Sold Up to $15K Worth of GSK Stockbenzinga.com
Via Benzinga · September 11, 2025
Robert F. Kennedy Took Fire From Both Republicans And Democrats Over Vaccine Overhauls: GOP Senators Defend Trump's Operation Warp Speedbenzinga.com
Secretary for Health and Human Services, Robert F. Kennedy Jr., faced bipartisan backlash during a combative Senate hearing on Thursday, as both Republicans and Democrats criticized his controversial vaccine policies and the abrupt firing of Centers for Disease Control and Prevention Director Susan Monarez.
Via Benzinga · September 5, 2025
Robert F. Kennedy Jr.'s Vaccine Shake-Up Sparks Coast-To-Coast Divide: West Coast Creates Health Alliance, Florida Rolls Back Requirementsbenzinga.com
California, Oregon and Washington form regional vaccine alliance to counter federal guidance under Robert F. Kennedy Jr. as Florida eliminates state mandates.
Via Benzinga · September 4, 2025
Florida Chooses 'Medical Freedom' As State Plans To End Vaccine Mandates, Even For Schools: Experts Warn Of 'Major Disaster'benzinga.com
Florida plans to end all statewide vaccine mandates, even those required for school attendance, framing the move as a defense of individual liberties, which has since received pushback from public health experts.
Via Benzinga · September 4, 2025
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?benzinga.com
Wave Life Sciences shares early WVE-006 trial results in alpha-1 antitrypsin deficiency, reporting durable protein production and favorable safety.
Via Benzinga · September 3, 2025
Upstream's New Sinus Treatment Cuts Need For Surgery, Early Trial Findsbenzinga.com
Upstream Bio's Phase 2 trial of verekitug in chronic rhinosinusitis met all endpoints, showing reduced nasal polyps, congestion, and need for surgery.
Via Benzinga · September 2, 2025
Bernie Sanders Demands Health Secretary RFK Jr.'s Resignation As CDC Leadership Crisis Deepensbenzinga.com
Senator Bernie Sanders called for HHS Secretary RFK Jr.'s resignation over his anti-vaccine policies, ousting of CDC Director Susan Monarez.
Via Benzinga · August 30, 2025
Elizabeth Warren Slams Trump's CDC Purge: Calls Out RFK Jr's Statements On Measles Vaccines — 'These Fools Can't Be Trusted With Your Health'benzinga.com
Sen. Elizabeth Warren (D-Mass.) is sounding the alarm on President Donald Trump's attempts at overhauling leadership at the Centers for Disease Control and Prevention, warning of risks to public health.
Via Benzinga · August 29, 2025
Dynavax Says Investigational Shingles Vaccine At Par With GSK's Vaccine In Early-Stage Studybenzinga.com
Dynavax's Z-1018 shingles vaccine matched Shingrix in immune response with fewer side effects, advancing to Phase 2 in older adults in 2025.
Via Benzinga · August 21, 2025
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plansbenzinga.com
CVS rejected coverage of Gilead's new HIV prevention drug Yeztugo, citing regulatory and financial factors, while facing nearly $290 million in Medicare overcharge penalties.
Via Benzinga · August 21, 2025